Skip to main content
SpringerLink
Log in

Secondary Prevention with Calcium Antagonists after Acute Myocardial Infarction

  • Published:
Drugs Aims and scope Submit manuscript

Summary

Experimental studies have demonstrated that the 3 calcium antagonists nifedipine, diltiazem, and verapamil have a comparable effect in the prevention of myocardial damage during ischaemia. Secondary prevention trials after acute myocardial infarction, which aimed at improving survival and preventing reinfarction, nevertheless demonstrated pronounced differences between the 3 drugs. Nifedipine had no effect on reinfarction or death. Diltiazem had no overall effect but prevented first reinfarction or cardiac death (cardiac events) in patients without heart failure, and increased cardiac events in patients with heart failure before randomisation. Verapamil prevented first reinfarction or death (major events); the most pronounced effect was found in patients without heart failure before randomisation. Verapamil did not have detrimental effects in patients treated for heart failure before randomisation. Differences between trials and between drugs explaining the different clinical findings are evaluated.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Beller GA. Calcium antagonists in the treatment of Prinzmetal’s angina and unstable angina pectoris. Circulation 81(Suppl. IV): IV78–IV87, 1989

    Google Scholar 

  • Betocchi S, Piscione F, Perrone-Filardi P, Pace L, Cappilli-Bigazzi M, et al. Effects of intravenous verapamil on left ventricular relaxation and filling in stable angina pectoris. American Journal of Cardiology 66: 818–825, 1990

    Article  PubMed  CAS  Google Scholar 

  • Bigger JT, Coromilas J, Rolnitzky LM, Fleiss JL, Kjeiger RE, the Multicenter Diltiazem Postinfarction Trial Investigators. Effect of diltiazem on cardiac rate and rhythm after myocardial infarction. American Journal of Cardiology 65: 539–546, 1990

    Article  PubMed  Google Scholar 

  • Boden WE, Krone RJ, Kjeiger RE, Oakes D, Greenberg H, et al. the Multicenter Diltiazem Post-Infarction Trial Research Group. Electrocardiographic subset analysis of diltiazem administration on long-term outcome after acute myocardial infarction. American Journal of Cardiology 67: 335–342, 1991

    Article  PubMed  CAS  Google Scholar 

  • Boissel JP, Leizorovicz A, Picolet H, Peyrieux JC, the APSI Investigators. Secondary prevention after high risk acute myocardial infarction with low-dose acebutolol. American Journal of Cardiology 67: 251–260, 1991

    Google Scholar 

  • Danish Study Group on Verapamil in Myocardial Infarction. Verapamil in acute myocardial infarction. European Heart Journal 5: 516–528, 1984

    Google Scholar 

  • Danish Study Group on Verapamil in Myocardial Infarction. The effect of verapamil on mortality and major events after myocardial infarction. The Danish Verapamil Infarction Trial II (DAVIT II). American Journal of Cardiology 66: 779–785, 1990a

    Article  Google Scholar 

  • Danish Study Group on Verapamil in Myocardial Infarction. Secondary prevention with verapamil after myocardial infarction. American Journal of Cardiology 66: 331–401, 1990b

    Google Scholar 

  • Gibson RS. Management of acute non-Q-wave myocardial infarction. The role of prophylactic diltiazem therapy and indications for predischarge coronary arteriography. Drugs 42(Suppl. 2): 28–37, 1991

    Article  PubMed  Google Scholar 

  • Gibson RS, Boden WE, Theroux P, Strauss HD, Pratt CM, et al. Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomised multicenter trial. New England Journal of Medicine 315: 423–429, 1986

    Article  PubMed  CAS  Google Scholar 

  • Goldstein RE, Boccuzzi SJ, Cruess D, Nattel S, the Adverse Experience Committee, and the Multicenter Diltiazem Postinfarction Research Group. Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. Circulation 83: 52–60, 1991

    Article  PubMed  CAS  Google Scholar 

  • Hansen JF. Calcium antagonists and myocardial infarction. Cardiovascular Drugs and Therapy 5: 665–670, 1991

    Article  PubMed  CAS  Google Scholar 

  • Israeli SPRINT Study Group. Secondary Prevention Reinfarction Israeli Nifedipine Trial (SPRINT). A randomized intervention trial of nifedipine in patients with acute myocardial infarction. European Heart Journal 9: 354–364, 1988

    Google Scholar 

  • Kloner RA, Braunwald E. Effect of calcium antagonists on infarcting myocardium. American Journal of Cardiology 59: 84B–94B, 1987

    Article  PubMed  CAS  Google Scholar 

  • Lahiri A, Rodrigues AE, Caboni PR, Raftery ER. Effect of long-term treatment with calcium antagonist on left ventricular diastolic function in stable angina and heart failure. Circulation 81(Suppl. III): III–130–III–138, 1990

    Google Scholar 

  • Lichstein E, Hager WD, Gregory JJ, Fleiss JL, Rolnitzky LM, et al. the Multicenter Diltiazem Postinfarction Research Group. Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure. Journal of the American College of Cardiology 16: 1327–1332, 1990

    Article  PubMed  CAS  Google Scholar 

  • Multicenter Diltiazem Postinfarction Trial Research Group. The effect of diltiazem on mortality and reinfarction after myocardial infarction. New England Journal of Medicine 319: 385–392, 1988

    Article  Google Scholar 

  • Nayler WG. Calcium antagonists and the ischemic myocardium. International Journal of Cardiology 15: 267–285, 1987

    Article  PubMed  CAS  Google Scholar 

  • Nayler WG. Basic mechanisms involved in the protection of the ischaemic myocardium: the role of calcium antagonists. Drugs 42(Suppl. 2): 21–27, 1991

    Article  PubMed  CAS  Google Scholar 

  • Opie LH. Clinical use of calcium channel antagonist drugs, 2nd ed., Kluwer Academic Publishers, Boston, 1990

    Google Scholar 

  • Opie LH. Calcium antagonists post infarction: the significance of experimental studies on potentially lethal early ischemic ventricular arrhythmias. Cardiovascular Drugs and Therapy 5: 671–676, 1991

    Article  PubMed  CAS  Google Scholar 

  • Packer M. Combined beta-adrenergic and calcium-entry blockade in angina pectoris. New England Journal of Medicine 320: 709–718, 1989

    Article  PubMed  CAS  Google Scholar 

  • Persson S. Calcium antagonists in secondary prevention after myocardial infarction. Drugs 42(Suppl. 2): 54–60, 1991

    Article  PubMed  Google Scholar 

  • Rafflenbeul W, Ebner F. Myocardial infarction: secondary prevention with nifedipine. Drugs 42(Suppl 2): 38–42, 1991

    Article  PubMed  Google Scholar 

  • Richardt G, Haass M, Schömig A. Calcium antagonists and cardiac noradrenaline release in ischemia. Journal of Molecular and Cellular Cardiology 23: 269–277, 1991

    Article  PubMed  CAS  Google Scholar 

  • Serato JF, Zaret BL, Schulman DS, Black HR, Soufer R. Usefulness of verapamil on congestive heart failure associated with abnormal left ventricular filling and normal left ventricular systolic performance. American Journal of Cardiology 66: 981–986, 1990

    Article  Google Scholar 

  • SPRINT Study Group. The secondary prevention re-infarction Israeli nifedipine trial (SPRINT II): design and methods, results. European Heart Journal 9(Suppl. I): 350A, 1988

    Google Scholar 

  • Yusuf S, Held P, Furberg C. Update of effects of calcium antagonists in mycoardial infarction or angina in light of the secondary Danish Verapamil Infarction Trial (DAVIT II) and other recent studies. American Journal of Cardiology 67: 1295–1297, 1991

    Article  PubMed  CAS  Google Scholar 

  • Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Betablockade during and after myocardial infarction. An overview of the randomized trials. Progress in Cardiovascular Diseases 27: 335–371, 1985

    Article  PubMed  CAS  Google Scholar 

  • Yusuf S, Wittes J, Friedman L. Overview of results of randomized clinical trials in heart disease. I. Treatment following myocardial infarction. Journal of the American Medical Association 260: 2088–2093, 1988

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiology, Hvidovre University Hospital, DK-2650, Hvidovre, Denmark

    Jørgen Fischer Hansen

Authors
  1. Jørgen Fischer Hansen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hansen, J.F. Secondary Prevention with Calcium Antagonists after Acute Myocardial Infarction. Drugs 44 (Suppl 1), 33–43 (1992). https://doi.org/10.2165/00003495-199200441-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199200441-00007

Keywords

Search

Navigation